TGFB1 and hepatocellular carcinoma: In particular, the Hep3B, HepG2 and PLC hepatoma cell lines were found to have low TGF-β and Smad7 levels and strong Smad3 transcriptional activity and were thus sensitive to TGF-β cytostatic activity, representative of the early stages of chronic liver disease [108].